Clinical Trial Update: Safety and Efficacy Study of Gevokizumab to Treat Non-infectious Uveitis Controlled With Systemic Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating gevokizumab for non-infectious uveitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Gevokizumab (gevokizumab)

Snippet

Sponsor: XOMA (US) LLC | Conditions: Uveitis | Phase 3 | Status: TERMINATED